Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data PureCycle Technologies, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0
0
8.36
Research and development
0.65
3.69
4.35
6.62
6.48
5.93
Selling, general and administrative
28
57.6
53.2
55.3
53.1
59.5
Operating expenses
37.2
69.6
81.3
114
145
190
Operating income
-114
-145
-181
Interest expense
4.11
7.47
2.31
31.4
56.9
64.4
Interest income
0.82
4.95
10.9
5.19
5.86
Other non-operating income
-15.8
-7.92
-3.43
12.8
-144
-0.16
Pre-tax income
-53
-77.5
-84.7
-101
-289
-182
Income tax
0
0
0
0.65
-0.08
0.97
Net income
-53
-77.5
-84.7
-102
-289
-183
EBITDA
-98
-114
-152
EPS, basic
-2.06
-0.75
-0.54
-0.62
-1.75
-1.08
EPS, diluted
-2.06
-0.79
-0.55
-0.63
-1.75
-1.21
Shares, basic (weighted)
27.3
103
156
164
165
179
Shares, diluted (weighted)
27.3
103
156
164
165
180
Balance sheet
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
64.5
33.4
63.9
73.4
15.7
157
Short-term investments
0
167
98.6
48.2
0
13.6
Receivables
0
2.01
Inventory
4.79
8.09
13.8
Other current assets
0.45
2.71
4.88
10.5
13.5
9.88
Total current assets
64.9
345
236
163
53.9
198
Property, plant and equipment
74.1
225
506
639
674
658
Lease right-of-use assets
0
19.1
29.8
56.8
54.2
Total assets
408
665
861
1,039
798
923
Accounts payable
1.06
1.4
1.67
2.88
6.6
9.25
Accrued liabilities
26.9
35.5
35.1
35.4
43.3
42.8
Short-term debt
0
9.15
12.9
Total current liabilities
33.1
38.5
38.3
55.6
90.9
87.6
Long-term debt
26.5
233
234
Lease liabilities
0
16.6
27.3
54.7
52.4
Other non-current liabilities
1
1.07
1.14
1.81
5.51
2.71
Total liabilities
296
283
350
619
618
572
Total debt
250
250
9.15
12.9
Paid-in capital
192
539
754
764
814
862
Retained earnings
-80.7
-158
-243
-344
-633
-816
Other comprehensive income
0
-0.24
-0.64
-0.03
0.08
-0.31
Shareholders' equity
112
382
511
420
180
45.9
Total equity
112
382
511
420
180
45.9
Total liabilities and equity
408
665
861
1,039
798
923
Shares outstanding
0
128
164
164
174
180
Cash flow statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-53
-77.5
-84.7
-102
-289
-183
Depreciation and amortization
1.9
2.28
3.61
15.9
31.3
29.1
Stock-based compensation
5.63
22.6
10.8
11.8
11.7
14.9
Deferred income tax
0
0
0
0.65
-0.08
0.97
Change in receivables
0
0
-2.01
Change in inventory
-0.27
-4.48
-3.3
-1.28
Change in payables
0.23
-0.29
0.09
0.42
4.78
2.54
Cash from operations
-18
-54.5
-65.5
-94.9
-145
-143
Capital expenditures
-29.8
-137
-287
-154
-55.6
-40.8
Purchases of investments
0
-229
-192
-57.6
-30.6
-13.6
Sales and maturities of investments
0
37.8
189
21
Cash from investing
-29.8
-306
-218
-102
-7.01
-54.5
Stock issued
107
1
206
0
38.2
33.5
Share buybacks
0
-1.7
-1.64
-1.37
-1.62
-4.93
Cash from financing
378
293
248
272
-109
324
Net change in cash
330
-66.7
-36.3
75
-261
127
Free cash flow
-47.8
-192
-353
-249
-200
-184
Interest paid
2.14
1.5
1.3
13.9
42.4
36.1
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.66 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-1,317.0%
Operating income / revenue.
EBITDA margin
-1,104.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-1,619.0%
Net income / revenue.
FCF margin
-1,542.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-1,161.0%
Cash from operations / revenue.
Return on equity (ROE)
-1,437.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-22.2%
Net income / average total assets.
R&D / revenue
43.3%
Research and development expense / revenue.
SG&A / revenue
375.8%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
70.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
380.8%
Capital expenditures / revenue.
D&A / revenue
212.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
-74.6%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-55.2%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-16.3%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
15.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
2.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
17.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
9.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
4.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
45.9%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.60x
Current assets / current liabilities.
Quick ratio
2.30x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
2.24x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.07
Revenue / diluted weighted shares.
FCF per share
-$1.15
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.87
Cash from operations / diluted weighted shares.
Book value per share
$0.08
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
68.0x
Market cap / revenue.
P/B
60.4x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
60.4x
Market cap / tangible book value, when positive.
EV/Sales
51.7x
Enterprise value / revenue.
FCF yield
-22.7%
Free cash flow / market cap.
Earnings yield
-23.8%
Net income / market cap (the inverse of P/E).
Shareholder yield
0.5%
(Dividends paid + share buybacks) / market cap.
What was PureCycle Technologies, Inc.'s revenue in fiscal 2025?
PureCycle Technologies, Inc. reported revenue of $8.4M for fiscal 2025.
Was PureCycle Technologies, Inc. profitable in fiscal 2025?
No. It reported a net loss of $182.6M.
How much free cash flow did PureCycle Technologies, Inc. generate in fiscal 2025?
Cash from operations of $142.7M minus capital expenditures of $40.8M left free cash flow of -$183.6M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.